Global pharma companies face rising local pharmacovigilance (PV) and medical information (MI) demands, but shrinking budgets and resources hinder compliance. Trends include increasing safety activity volumes, evolving regulations, and changing HCP/patient behaviors. Building scalable, consistent global models improves oversight, reduces costs, and enhances flexibility. Outsourcing PV/MI to expert partners provides regulatory intelligence, QPPV support, and language coverage, while AI-enabled MI systems manage high inquiry volumes efficiently. IQVIA’s Local Affiliate Product Services (LAPS) deliver 24/7 support, automation, and compliance infrastructure across 170+ countries, ensuring efficiency and quality in local operations.

Join for free to read